Hence, the aim of this prospective cohort study was to investigate the associations of obesity, measured as several anthropometric factors, with CRC risk according to KRAS and BRAF mutation status of the tumours, overall, and with particular reference to potential sex differences. This evidence concerns the gene KRAS and obesity due to melanocortin 4 receptor deficiency.